Apellis Pharmaceuticals, Inc. (APLS)

20.53 +0.20 (+0.98%) USD  |  NASDAQ  |  Jan 15, 16:00
20.53 0.00 (0.00%) After-Hours: 18:20
More

Apellis Pharmaceuticals Underperform Recommendations

Underperform Recommendations Chart

View Underperform Recommendations for APLS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Underperform Recommendations Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Underperform Recommendations Range, Past 5 Years

View Underperform Recommendations Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Underperform Recommendations Benchmarks

View Underperform Recommendations Benchmarks
Start Trial
Biogen, Inc. Upgrade
Amicus Therapeutics, Inc. Upgrade
Fortress Biotech, Inc. Upgrade
Ultragenyx Pharmaceutical, Inc. Upgrade
Fulcrum Therapeutics, Inc. Upgrade